These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20230379)

  • 41. High-intensity focused ultrasound in the management of prostate cancer.
    Chaussy C; Thüroff S
    Expert Rev Med Devices; 2010 Mar; 7(2):209-17. PubMed ID: 20214427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term follow-up of patients with metastatic renal cell carcinoma treated with intravenous recombinant interleukin-2 in Europe.
    Negrier S; Maral J; Drevon M; Vinke J; Escudier B; Philip T
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S93-8. PubMed ID: 10685667
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Management approaches to small renal tumours.
    Cambio AJ; Evans CP
    BJU Int; 2006 Mar; 97(3):456-60. PubMed ID: 16469007
    [No Abstract]   [Full Text] [Related]  

  • 44. Cardiac intervention using high-intensity focused ultrasound: creation of interatrial communication in beating heart of an anesthetized rabbit.
    Fujisaki M; Chiba T; Enosawa S; Dohi T; Takamoto S
    Ultrasound Obstet Gynecol; 2010 Nov; 36(5):607-12. PubMed ID: 20842654
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preliminary experience using high intensity focused ultrasound for treating liver metastasis from colon and stomach cancer.
    Park MY; Jung SE; Cho SH; Piao XH; Hahn ST; Han JY; Woo IS
    Int J Hyperthermia; 2009 May; 25(3):180-8. PubMed ID: 19212862
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer.
    Muto S; Yoshii T; Saito K; Kamiyama Y; Ide H; Horie S
    Jpn J Clin Oncol; 2008 Mar; 38(3):192-9. PubMed ID: 18281309
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunotherapy of disseminated renal cell carcinoma.
    Javapour N
    Md Med J; 1989 Nov; 38(11):963. PubMed ID: 2586256
    [No Abstract]   [Full Text] [Related]  

  • 48. Transmission electron microscopy of VX2 liver tumors after high-intensity focused ultrasound ablation enhanced with SonoVue.
    Li Q; Du J; Yu M; He G; Luo W; Li H; Zhou X
    Adv Ther; 2009 Jan; 26(1):117-25. PubMed ID: 19096769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [High intensity focused ultrasound combined with endocrine therapy in treating prostate cancer].
    Hua LX; Wu HF; Sui YG; Zhang W; Qian LX; Song NH; Zhang JX
    Zhonghua Nan Ke Xue; 2005 Mar; 11(3):195-7. PubMed ID: 15804111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ablative techniques for the management of kidney cancer.
    Hafron J; Kaouk JH
    Nat Clin Pract Urol; 2007 May; 4(5):261-9. PubMed ID: 17483811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-intensity focused ultrasound (HIFU) is not indicated for treatment of primary bone sarcomas.
    Bielack SS; Marina N; Bernstein M
    Cancer; 2011 Jun; 117(12):2822; author reply 2822-3. PubMed ID: 21656761
    [No Abstract]   [Full Text] [Related]  

  • 52. Non-invasive pulsed cavitational ultrasound for fetal tissue ablation: feasibility study in a fetal sheep model.
    Kim Y; Gelehrter SK; Fifer CG; Lu JC; Owens GE; Berman DR; Williams J; Wilkinson JE; Ives KA; Xu Z
    Ultrasound Obstet Gynecol; 2011 Apr; 37(4):450-7. PubMed ID: 21433165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-intensity focused ultrasound ablation of rabbit kidney tumors.
    Adams JB; Moore RG; Anderson JH; Strandberg JD; Marshall FF; Davoussi LR
    J Endourol; 1996 Feb; 10(1):71-5. PubMed ID: 8833733
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiac ablation by transesophageal high intensity focused ultrasound.
    Jiang CX; Yu RH; Ma CS
    Chin Med J (Engl); 2010 Sep; 123(17):2451-3. PubMed ID: 21034564
    [No Abstract]   [Full Text] [Related]  

  • 55. Nonlinear 3-D simulation of high-intensity focused ultrasound therapy in the Kidney.
    Suomi V; Jaros J; Treeby B; Cleveland R
    Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():5648-5651. PubMed ID: 28269536
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Re.: Natural history of renal cortical neoplasms during active surveillance with follow-up longer than 5 years.
    Taneja SS
    J Urol; 2011 May; 185(5):1639-40. PubMed ID: 22088687
    [No Abstract]   [Full Text] [Related]  

  • 57. Focused ultrasound surgery.
    Elias WJ; Kassell NF
    Neurosurg Focus; 2012 Jan; 32(1):Introduction. PubMed ID: 22208900
    [No Abstract]   [Full Text] [Related]  

  • 58. Unlocking the secret of the obesity paradox in renal tumours.
    Santoni M; Cortellini A; Buti S
    Lancet Oncol; 2020 Feb; 21(2):194-196. PubMed ID: 31870810
    [No Abstract]   [Full Text] [Related]  

  • 59. The contemporary role of ablative treatment approaches in the management of renal cell carcinoma (RCC): focus on radiofrequency ablation (RFA), high-intensity focused ultrasound (HIFU), and cryoablation.
    Klatte T; Kroeger N; Zimmermann U; Burchardt M; Belldegrun AS; Pantuck AJ
    World J Urol; 2014 Jun; 32(3):597-605. PubMed ID: 24700308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment Planning and Aberration Correction Algorithm for HIFU Ablation of Renal Tumors.
    Rosnitskiy PB; Khokhlova TD; Schade GR; Sapozhnikov OA; Khokhlova VA
    IEEE Trans Ultrason Ferroelectr Freq Control; 2024 Mar; 71(3):341-353. PubMed ID: 38231825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.